Protein sequence (P0C2X0, Met17-Ser467, with C-His tag) MHSSALLCCLVLLTGVRAKFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLVGTALQVKMPKSHKAIQADGWMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESIEQTKQGTWLNPGFPPQSCGYATVTDAEAAIVQVTPHHVLVDEYTGEWVDSQFINGKCSNDICPTVHNSTTWHSDYKVKGLCDSNLISMDITFFSEDGELSSLGKKGTGFRSNYFAYETGDKACKMQYCKHWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTSVDVSLIQDVERILDYSLCQETWSKIRAGLPISPVDLSYLAPKNPGTGPVFTIINGTLKYFETRYIRVDIAAPILSRMVGMISGTTTERVLWDDWAPYEDVEIGPNGVLRTSSGYKFPLYMIGHGMLDSDLHLSSKAQVFEHPHIQDAASQLPDGETLFFGDTGLSKNPIEFVEGWFSSWKSSIAS
Predicted MW: 51.8 kDa Observed MW: 65 kDa
Supplied as a 0.2 μm filtered solution of 0.2M PBS, pH7.4.
12 months from date of receipt, -20℃ as supplied.
The VSV-G glycoprotein is a trimeric protein that forms spikes on the surface of the vesicular stomatitis virus, contributing to its structural integrity and functionality. Each monomer within the trimer is composed of a single polypeptide chain, which folds into distinct domains that facilitate its role in viral processes. In addition to its structural roles, the VSV-G glycoprotein is involved in immune evasion. It can modulate host immune responses, allowing the virus to persist and replicate within the host. The VSV-G glycoprotein has emerged as a tool in the field of gene therapy, largely due to its ability to facilitate the delivery of genetic material into target cells.
2μg(R: reducing conditions; NR: non-reducing conditions)